417 related articles for article (PubMed ID: 16757589)
1. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
[TBL] [Abstract][Full Text] [Related]
2. Detection of the rtA181V/T and rtN236T mutations associated with resistance to adefovir dipivoxil using a ligase detection reaction assay.
Wang YZ; Xiao JH; Ruan LH; Zhang HY; Chen M; Pu XK; Shen HY; Wu GX
Clin Chim Acta; 2009 Oct; 408(1-2):70-4. PubMed ID: 19651117
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of therapy in patients with chronic hepatitis B virus.
Arrese E; Basaras M; Blanco S; Ruiz P; Cisterna R
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
[TBL] [Abstract][Full Text] [Related]
4. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
Dai CY; Chuang WL; Hsieh MY; Lee LP; Huang JF; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
Antiviral Res; 2007 Aug; 75(2):146-51. PubMed ID: 17400303
[TBL] [Abstract][Full Text] [Related]
5. [Dissection of mechanism for the adefovir dipivoxil resistance in chronic hepatitis B patients].
Zeng AZ; Lu P; Deng H; Cai SF; Yang C; Xin XJ; Guo JJ; Li QL; Deng XH; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):730-4. PubMed ID: 19874686
[TBL] [Abstract][Full Text] [Related]
6. An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus.
Hu Y; Zhang WL; Xie SL; Zhao Y; Hu JL; Cai XF; Lai GQ; Huang AL
Genet Mol Res; 2012 Jan; 11(1):53-60. PubMed ID: 22290465
[TBL] [Abstract][Full Text] [Related]
7. The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil.
Liu Y; Li X; Xin S; Xu Z; Chen R; Yang J; Liu L; Wong VW; Yang D; Chan HL; Xu D
J Viral Hepat; 2015 Mar; 22(3):328-34. PubMed ID: 25132017
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of a novel adefovir dipivoxil resistance associated mutation, rtN236V, of HBV from a large cohort of HBV-infected patients.
Liu Y; Liu W; Li X; Xu Z; Wang X; Li C; Chen L; Xin S; Xu D
Antivir Ther; 2014; 19(6):551-8. PubMed ID: 24710668
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen.
Svarovskaia ES; Curtis M; Zhu Y; Borroto-Esoda K; Miller MD; Berg T; Lavocat F; Zoulim F; Kitrinos KM
J Viral Hepat; 2013 Feb; 20(2):131-40. PubMed ID: 23301548
[TBL] [Abstract][Full Text] [Related]
10. Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil.
Chen CH; Wang JH; Lee CM; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS
Antivir Ther; 2006; 11(6):771-8. PubMed ID: 17310821
[TBL] [Abstract][Full Text] [Related]
11. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
Arslan U; Ural O; Findik D
Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection].
Moon JH; Cho M; Yoon KT; Bae JH; Heo J; Kim GH; Kang DH; Song GA
Korean J Hepatol; 2008 Dec; 14(4):503-12. PubMed ID: 19119245
[TBL] [Abstract][Full Text] [Related]
13. rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B.
Liu LJ; Wang JH; Du SC; Tian JH; Yang RF; Wei L
J Viral Hepat; 2010 Mar; 17 Suppl 1():66-72. PubMed ID: 20586936
[TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B.
Santantonio T; Fasano M; Durantel S; Barraud L; Heichen M; Guastadisegni A; Pastore G; Zoulim F
Antivir Ther; 2009; 14(4):557-65. PubMed ID: 19578241
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.
Qi X; Xiong S; Yang H; Miller M; Delaney WE
Antivir Ther; 2007; 12(3):355-62. PubMed ID: 17591025
[TBL] [Abstract][Full Text] [Related]
16. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
Mese S; Arikan M; Cakiris A; Abaci N; Gumus E; Kursun O; Onel D; Ustek D; Kaymakoglu S; Badur S; Yenen OS; Bozkaya E
J Gen Virol; 2013 Dec; 94(Pt 12):2729-2738. PubMed ID: 24045109
[TBL] [Abstract][Full Text] [Related]
17. Detection of lamivudine- or adefovir-resistant hepatitis B virus mutations by a liquid array.
Liu H; Mao R; Fan L; Xia J; Li Y; Yin Y; Li X; Zhao X; Guo H; Zhu H; Zhang Y; Kang Y; Zhang J
J Virol Methods; 2011 Jul; 175(1):1-6. PubMed ID: 21513743
[TBL] [Abstract][Full Text] [Related]
18. rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy.
Lee YS; Chung YH; Kim JA; Jin YJ; Park WH; Kim SE; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2012 Feb; 27(2):300-5. PubMed ID: 21777282
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing inadequate or suboptimal response to adefovir with or without genotypic resistance.
Zhou X; Kuang X; Fan K; Zhang C; Deng G; Wang H; Wang Y
J Med Virol; 2012 Jul; 84(7):1030-6. PubMed ID: 22585719
[TBL] [Abstract][Full Text] [Related]
20. Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B.
Akman SA; Kose S; Halicioglu O
Int J Infect Dis; 2010 Mar; 14(3):e236-9. PubMed ID: 19665408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]